Company Medivir AB (publ) OTC Markets
Equities
MVRBF
SE0020181014
Biotechnology & Medical Research
Business Summary
Number of employees: 10
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 8 | 100.0 % | +73.16% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
46.9
%
| - | - | 4 | 46.9 % | - |
Europe, Other
43.3
%
| 4 | 80.8 % | 3 | 43.3 % | -7.16% |
Rest of the World
4.8
%
| 0 | 9.9 % | 0 | 4.8 % | -16.21% |
Sweden
2.5
%
| 0 | 5.0 % | 0 | 2.5 % | -13.12% |
Nordic Region, Other
2.4
%
| 0 | 4.2 % | 0 | 2.4 % | -0.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Pia Baumann
CTO | Chief Tech/Sci/R&D Officer | 58 | 23-02-19 |
Malene Jensen
CTO | Chief Tech/Sci/R&D Officer | 54 | 21-09-30 |
Fredrik Öberg
CTO | Chief Tech/Sci/R&D Officer | 59 | 10-12-31 |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Bengt Westermark
BRD | Director/Board Member | 79 | 17-05-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 864,750 | 0 | 864,750 ( 100.00 %) | 64.10 % |
Stock B | 1 | 112,053,218 | 72,375,356 ( 64.59 %) | 11,413 ( 0.0102 %) |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.39% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.57% | 16.81B | |
+37.41% | 12.54B | |
-24.07% | 8.09B |